Whether bringing a novel therapy to market or altering current devices for lifecycle management, companies must determine the best selection for administration without affecting drug efficacy, quality, and safety. In this article from Life Science Leader, Kymanox experts, Scott Arra, Sr. Director, Business Development and Evan Edwards, Chief Development Officer discuss the multitude of factors to consider when determining the right delivery system for bringing drugs and devices to market.